11
Participants
Start Date
July 31, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Placebo
Enrolled volunteers will be randomized on Day 8 to receive placebo (n=2) or study medication (n=8). Placebo serves only to maintain the blind and is not a comparator.
Cabergoline
Enrolled volunteers that receive study medication (n=8) will receive cabergoline 0.25 mg twice weekly.
Michael E. DeBakey VA Medical Center, Houston
National Institute on Drug Abuse (NIDA)
NIH
Baylor College of Medicine
OTHER